Log in to save to my catalogue

Systemic antibody-oligonucleotide delivery to the central nervous system ameliorates mouse models of...

Systemic antibody-oligonucleotide delivery to the central nervous system ameliorates mouse models of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2556161037

Systemic antibody-oligonucleotide delivery to the central nervous system ameliorates mouse models of spinal muscular atrophy

About this item

Full title

Systemic antibody-oligonucleotide delivery to the central nervous system ameliorates mouse models of spinal muscular atrophy

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2021-07

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Antisense oligonucleotides (ASOs) have emerged as one of the most innovative new genetic drug modalities, however, the high molecular weight limits their bioavailability for otherwise treatable neurological disorders. We investigated conjugation of ASOs to an antibody against the murine transferrin receptor (TfR), 8D3130, and evaluated it via syste...

Alternative Titles

Full title

Systemic antibody-oligonucleotide delivery to the central nervous system ameliorates mouse models of spinal muscular atrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2556161037

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2556161037

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.07.29.454272